Cancer Stem Cells in Hepatocellular Carcinoma

Area of Science:

• Oncology
• Stem Cell Biology

Background:

• Hepatocellular carcinoma (HCC) is a leading cause of cancer deaths globally.
• Poor prognosis is attributed to late detection, treatment resistance, and recurrence.
• Cancer stem cells (CSCs) are increasingly recognized for driving tumor heterogeneity.

Purpose of the Study:

• To review the biological characteristics of CSCs in HCC.
• To explore the potential of CSCs as diagnostic and prognostic markers.
• To discuss CSCs as therapeutic targets in HCC.

Main Methods:

• Literature review focusing on CSCs in hepatocellular carcinoma.
• Analysis of studies identifying and characterizing CSCs in HCC cell lines and tumors.
• Examination of research on CSC markers and their clinical implications.

Main Results:

• CSCs, also known as tumor-initiating cells, have been isolated from HCC.
• Hepatic progenitor markers are used to identify CSCs in HCC.
• A minor population of HCC cells exhibits self-renewal and recapitulates tumor heterogeneity.

Conclusions:

• CSCs play a critical role in HCC biology.
• CSCs hold promise as biomarkers for HCC diagnosis and prognosis.
• Targeting CSCs represents a potential therapeutic strategy for HCC.